Douglas Swirsky
-
Fibrocell’s ‘Butterfly Child’ Treatment Clears First Patient
Fibrocell Science’s newest gene therapy treatment is now spreading its wings after helping treat the first patient suffering from fragile, easily blistered skin associated with…
-
Exton’s Fibrocell Completes Transition with Changes in Leadership
Exton’s Fibrocell Science has made some changes in its leadership by appointing John Maslowski as Chief Executive Officer and Douglas Swirsky as Chairman of the…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
